Miguel Cuchacovich
Overview
Explore the profile of Miguel Cuchacovich including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
276
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Gonzalez P, Schinnerling K, Sepulveda-Gutierrez A, Maggi J, Hoyos L, Morales R, et al.
Front Immunol
. 2016 Nov;
7:458.
PMID: 27826300
Tolerogenic dendritic cells (TolDCs) are promising tools for therapy of autoimmune diseases, such as rheumatoid arthritis (RA). Here, we characterize monocyte-derived TolDCs from RA patients modulated with dexamethasone and activated...
2.
Cuchacovich M, Solanes F, Perez C, Verdaguer J, Verdaguer J, Castiglione E, et al.
J Ocul Pharmacol Ther
. 2015 Nov;
32(1):55-61.
PMID: 26562247
Purpose: To study the efficacy and incidence of treatment-related side effects of mycophenolate mofetil (MMF) therapy in patients with noninfectious inflammatory eye diseases. Methods: Retrospective cohort study of 27 Chilean...
3.
Gonzalez-Gronow M, Cuchacovich M, Francos R, Cuchacovich S, Blanco A, Sandoval R, et al.
J Neuroimmunol
. 2015 Oct;
287:1-8.
PMID: 26439953
Autoantibodies from autistic spectrum disorder (ASD) patients react with multiple proteins expressed in the brain. One such autoantibody targets myelin basic protein (MBP). ASD patients have autoantibodies to MBP of...
4.
Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients
Cuchacovich M, Bueno D, Carvajal R, Bravo N, Aguillon J, Catalan D, et al.
Clin Rheumatol
. 2014 Aug;
33(12):1707-14.
PMID: 25085274
Tumor necrosis factor (TNF) plays a pivotal role in the pathogenesis of rheumatoid arthritis (RA). This finding has led to the development of TNF blockers for RA treatment. However, response...
5.
Sabugo F, Espinoza-Araya R, Meneses M, Cuchacovich M
J Clin Rheumatol
. 2013 Dec;
20(1):42-4.
PMID: 24356475
A woman with severe and longstanding systemic lupus erythematosus presented with a 1-week history of fever up to 38°C and pain in her right flank. Computed tomography scan of the...
6.
Aravena O, Pesce B, Soto L, Orrego N, Sabugo F, Wurmann P, et al.
Immunobiology
. 2011 Aug;
216(12):1256-63.
PMID: 21840621
The aim of this work was to study the effect of anti-TNF treatment on CD4+ Th1, Th17 and regulatory T cells (Tregs), together with CD8+ T cells and NK cells...
7.
Catalan D, Aravena O, Zuniga R, Silva N, Escobar A, Sabugo F, et al.
Rheumatol Int
. 2011 Jul;
32(6):1819-25.
PMID: 21769486
Citrullinated vimentin (cVIM) is one of the antigens specifically targeted by anti-citrullinated protein antibodies (ACPA) in rheumatoid arthritis (RA) patients. The association between ACPA and certain HLA-DRB1 alleles, those coding...
8.
Soto L, Sabugo F, Catalan D, Wurmann P, Cermenatti T, Gatica H, et al.
Clin Rheumatol
. 2011 Jan;
30(3):391-5.
PMID: 21234628
The introduction of antitumor necrosis factor (TNF) agents has improved the outcome for many patients with rheumatoid arthritis (RA). To date, the only replicated genetic predictor of anti-TNF response is...
9.
Gonzalez-Gronow M, Cuchacovich M, Francos R, Cuchacovich S, Pilar Fernandez M, Blanco A, et al.
J Neuroimmunol
. 2010 Jun;
227(1-2):153-61.
PMID: 20576296
Autistic children show elevated serum levels of autoantibodies to several proteins essential for the function of normal brains. The voltage-dependent anion channel (VDAC) and hexokinase-I, a VDAC protective ligand, were...
10.
Cuchacovich M, Solanes F, Diaz G, Cermenati T, Avila S, Verdaguer J, et al.
Ocul Immunol Inflamm
. 2010 May;
18(3):200-7.
PMID: 20482399
Purpose: To prospectively compare 2 immunosupressive regimens in patients with active Vogt-Koyanagi-Harada disease in spite of systemic glucocorticoid treatment. Methods: Forty-four patients were diagnosed between 1998 and 2005. Twenty-one developed...